(Q33910132)

30 July 2017

1 reference

title

Chemotherapy for non-small cell lung cancer. (English)

1 reference

30 July 2017

1 reference

1 reference

Non-small Cell Lung Cancer Collaborative Group

series ordinal

1

1 reference

30 July 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

published in

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

CD002139

1 reference

Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Adjuvant cancer chemotherapy after resection of carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Comparison of radiotherapy alone and radiotherapy with chemotherapy using adriamycin and 5-fluorouracil in bronchogenic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Results of a E.O.R.T.C. randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: Prognostic factors and treatment results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Chemotherapy as an adjuvant to surgery in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Clinical research on the treatment of locally advanced lung cancer.Final report of VALG protocol 13 limited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Is there a role for preference assessments in research on quality of life in oncology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002139

10.1002/14651858.CD002139

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference